The Constitutional Battle Over FCA Qui Tams Continues
As we reported in September, the Eleventh Circuit rejected one of three constitutional challenges to the False Claims Act’s (FCA) qui tam provision in United States ex rel. Zafirov v. Florida Medical Associates, LLC. The Court overruled the district court and held that qui tam relators do not violate the Appointments Clause of Article II which requires that “officers” be appointed by the President subject to the advice and consent of the Senate. Relators, the Court found, are not “Officers of the United States” because they do not “occupy a continuing position established by law.
The court remanded the case for the district court to decide the Zafirov defendants’ two other constitutional challenges, which the district court did not address before: whether the FCA’s qui tam provision violates the Take Care and Vesting Clauses of Article II. Those challenges essentially ask whether Congress may authorize private parties such as relators to wield the Executive Branch’s enforcement power when the Executive Branch has declined to take over a qui tam case.
On remand, those challenges are back before U.S. District Judge Kathryn Mizelle, who issued the original Zafirov ruling. The defendants have told the district court that they will not seek rehearing or certiorari on the Appointments Clause ruling and that the remaining issues are fully briefed. The relator disagrees, and the United States government has asked to file a supplemental brief reflecting its current arguments following the change in Administration. The district court has set a status conference for Nov. 23 and directed the parties to address the Eleventh Circuit’s treatment of the Take Care and Vesting Clauses as separate challenges, what legal test applies to each, and whether the two clauses must still be analyzed together.
Meanwhile, the Eleventh Circuit has begun applying Zafirov to other pending appeals. On Nov. 12, in Gose v. Native American Services Corp., the court summarily reversed another Middle District of Florida judgment that rested solely on the Appointments Clause and, as in Zafirov, remanded for the district court to address the defendants’ Take Care and Vesting Clause arguments.
Support for all three of these constitutional arguments has been building since Justice Clarence Thomas’ dissent in United States ex rel. Polansky v. Executive Health Resources, Inc. in 2023. Justice Thomas observed that “[t]here are substantial arguments that the qui tam device is inconsistent with Article II;” Justices Brett Kavanaugh and Amy Coney Barrett agreed with Justice Thomas and signaled that the Court should consider the issue in an appropriate case.
That support to challenge the constitutionality of qui tams is now growing among judges in the Fifth Circuit, which remains bound by Riley v. St. Luke’s Episcopal Hospital, which upheld the constitutionality of FCA qui tams. Several Fifth Circuit judges contend that Riley is at odds with the Supreme Court’s more recent opinions on Article II and Presidential power. For example, in Montcrief v. Peripheral Vascular Associates, Judge Kyle Duncan wrote separately to “point out the constitutional flaws in the FCA’s qui tam device,” arguing that private relators exercise federal enforcement authority in tension with the Appointments Clause and the Take Care Clause. In Gentry v. Encompass Health Rehabilitation Hospital, Judge James Ho likewise urged the court, in an appropriate case, to revisit whether the FCA’s qui tam provisions present “serious constitutional problems.” And in Jackson v. Ventavia Research Group, Judge Don Willett recently wrote that Riley “binds us today, but it should not bind us forever,” questioning whether a private relator may speak for the Executive branch without answering to the Executive branch. Judge Willett described the Vesting and Take Care Clause objections as a “distinct—and stronger—problem” than the Appointments Clause challenge. Chief Judge Jennifer Elrod separately agreed that those concerns are “no doubt en banc worthy” and that, in a proper case, the Fifth Circuit may need to revisit Riley.
Zafirov may have closed the door on the Appointments Clause challenge in the Eleventh Circuit, but that argument is not foreclosed in other circuits or at the U.S. Supreme Court. Moreover, the Take Care and Vesting Clause challenges in Zafirov and other circuits may prove the stronger argument to prevent qui tams. The Vesting Clause argument is that Article II places “the executive Power,” including the power to bring civil enforcement actions on behalf of the United States, in the President alone, so Congress cannot hand that power to private relators. The Take Care Clause argument is that the President cannot “take Care that the Laws be faithfully executed” when relators who litigate in the government’s name are not appointed, supervised, or removable by the Executive Branch and need not follow Department of Justice policy. Neither argument depends on whether a relator holds an “office.” Both ask whether a private, financially interested party may control FCA litigation brought in the name of the United States after the Executive Branch has declined to do so.
With the right case and the right court—whether an en banc Fifth Circuit revisiting Riley or a district court ruling on remand in Zafirov or Gose—those challenges could succeed, and the question could reach the U.S. Supreme Court. For now, defendants in declined qui tams should continue to raise and preserve them.
Please contact A. Brian Albritton, Robert W. Gifford, Raquel Ramirez Jefferson or any member of the Phelps Health Care or White Collar Defense and Investigations team if you have questions or need advice or guidance.